Abeona Therapeutics CFO Edward Carr resigns; Joseph Vazzano appointed new CFO

ABEONA THERAPEUTICS INC.

Edward Carr resigns effective March 31, 2022; no disagreement with company.
Joseph Vazzano appointed CFO effective March 14, 2022; previously CFO of Avenue Therapeutics (ATXI).
Vazzano receives $360k base salary, 40% target bonus, 200k restricted shares; potential increase to $400k salary.
Vazzano to become principal financial and accounting officer on March 31, 2022.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Edward Carr

Chief Financial Officer

ABEO · ABEONA THERAPEUTICS INC.

Effective: 2022-03-31
Successor: Joseph Vazzano
Filed: March 9, 2022, 6:59 PM ET

On March 3, 2022, Edward Carr, Chief Financial Officer and Chief Accounting Officer of Abeona Therapeutics Inc. (the “Company”), notified the Company of his resignation effective March 31, 2022.

Appointed

Joseph Vazzano

Chief Financial Officer

ABEO · ABEONA THERAPEUTICS INC.

Effective: 2022-03-14
Filed: March 9, 2022, 6:59 PM ET

Also on March 3, 2022, the Board appointed Joseph Vazzano as Chief Financial Officer effective March 14, 2022.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Edward Carr resigned as Chief Financial Officer at ABEONA THERAPEUTICS INC..

Action: resigned
Role: Chief Financial Officer

Exact text from the filing

On March 3, 2022, Edward Carr, Chief Financial Officer and Chief Accounting Officer of Abeona Therapeutics Inc. (the “Company”), notified the Company of his resignation effective March 31, 2022.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Joseph Vazzano was appointed as Chief Financial Officer at ABEONA THERAPEUTICS INC..

Action: appointed
Role: Chief Financial Officer

Exact text from the filing

Also on March 3, 2022, the Board appointed Joseph Vazzano as Chief Financial Officer effective March 14, 2022.

View on SEC.gov

ABEONA THERAPEUTICS INC. filing history →

Source: SEC EDGAR

accession 0001493152-22-006398

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.